Tag #Drug Security

What immediate actions will the EU take to reduce its dependence on third countries for the production of critical medicines, and what are the specific implications for European healthcare security?

Five years after the COVID-19 pandemic exposed Europe's vulnerability in pharmaceutical supply chains, the EU still lacks a system guaranteeing sufficient critical medicines. This issue is now considered a matter of national security, highlighting the risk of shortages during geopolitical crises. The European Commission will present a key legislative proposal on March 11th to reduce reliance on third countries for medicine production.